1. Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
   Mengmeng Lin et al, 2022, Journal of Oncology CrossRef
2. The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620
   Jian-hua Zha et al, 2021, Frontiers in Oncology CrossRef
3. Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
   Preeti Gupta et al, 2021, Cancers CrossRef
4. Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics
   Xiaoling Zang et al, 2022, Journal of Proteome Research CrossRef
5. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
   A K M Nawshad Hossian et al, 2021, Scientific Reports CrossRef
6. Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis
   Chuanmeng Zhang et al, 2022, Disease Markers CrossRef
7. Sphingolipids in food and their critical roles in human health
   Xiaoxu Wang et al, 2021, Critical Reviews in Food Science and Nutrition CrossRef
8. Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage
   Saad A. Khan et al, 2021, Frontiers in Physiology CrossRef
9. Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters
   Anne Gomez-Brouchet et al, 2022, Cancers CrossRef
10. Is Sphingosine-1-Phosphate a Regulator of Tumor Vascular Functionality?
    Manale Karam et al, 2022, Cancers CrossRef
11. Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models
    Tristan Rupp et al, 2022, International Journal of Molecular Sciences CrossRef
12. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma
    Zhao-Shan Niu et al, 2020, World Journal of Gastroenterology CrossRef